Xynomic Pharmaceuticals
Latest round
- Series B
Last raised
- Jun 2018
Total raised
- Undisclosed
Investors
- 4
About Xynomic Pharmaceuticals
Xynomic Pharmaceuticals, Inc.Xynomic Pharmaceuticals focuses on developing cutting-edge oncology therapeutics and is headquartered in Shanghai, China. The company was founded by Yinglin Xu, who has a history of founding other ventures in the pharmaceutical space., Ltd.Xynomic Pharmaceuticals Holdings, Inc. specializes in the development and commercialization of advanced oncology therapeutics, with a primary focus on its lead drug candidate, Abexinostat. This drug aims to inhibit pathways tied to tumor growth and is currently being tested for efficacy in patients with follicular lymphoma and kidney cancer, as well as in combination with established therapies like Keytruda®.The revenue structure for Xynomic Pharmaceuticals mainly derives from clinical development activities and partnerships with healthcare providers and research institutions. Revenue is generated through the provision of proprietary therapies in the oncology sector, often facilitated by licensing agreements and collaborative development arrangements.Xynomic Pharmaceuticals is committed to expanding its product offerings and market reach. The company plans to launch new products targeting additional cancer types in the upcoming years, ensuring that they meet the evolving needs of patients.
Who invested in Xynomic Pharmaceuticals
4 investors across 1 round
See all investors in Xynomic Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 1, 2018
Amount
Undisclosed
Investors
Questions about Xynomic Pharmaceuticals
Who invested in Xynomic Pharmaceuticals?
Xynomic Pharmaceuticals has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xynomic Pharmaceuticals raised?
Xynomic Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xynomic Pharmaceuticals last raise money?
Xynomic Pharmaceuticals's most recent round on record is a Series B, in Jun 2018.
What does Xynomic Pharmaceuticals do?
Xynomic Pharmaceuticals is a pharmaceuticals company.
Where is Xynomic Pharmaceuticals headquartered?
Xynomic Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like Xynomic Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Xynomic Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Xynomic Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.